Cyanotech Corporation (CYAND)

Market Cap	3.25M -20.2%
Revenue (ttm)	25.27M +8.5%
Net Income	-1.78M
EPS	-0.25
Shares Out	7.39M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,770
Average Volume	11,187
Open	0.4400
Previous Close	0.4540
Day's Range	0.4400 - 0.4400
52-Week Range	0.2100 - 0.5740
Beta	-0.29
RSI	48.88
Earnings Date	Feb 13, 2026

About Cyanotech

Cyanotech Corporation, an agricultural company, engages in the production and sale of natural ingredients and dietary supplement products from microalgae for health and wellness markets. The company offers BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint, brain, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of protein, antioxidant carotenoids, and essential nutrients. It...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1983
• Employees: 83
• Stock Exchange: OTCMKTS
• Ticker Symbol: CYAND

Financial Performance

In fiscal year 2025, Cyanotech's revenue was $24.22 million, an increase of 4.96% compared to the previous year's $23.07 million. Losses were -$3.20 million, -39.19% less than in 2024.